XML 66 R56.htm IDEA: XBRL DOCUMENT v3.22.2.2
SHAREHOLDERS’ EQUITY (Details Narrative) - USD ($)
 1 Months Ended 3 Months Ended 9 Months Ended
Jul. 01, 2022
Jul. 14, 2021
Jul. 14, 2021
Feb. 17, 2021
Feb. 12, 2021
Jan. 18, 2021
Jul. 31, 2022
Apr. 30, 2022
Mar. 31, 2021
Feb. 28, 2021
Sep. 30, 2022
Jun. 30, 2022
Sep. 30, 2021
Mar. 31, 2021
Sep. 30, 2022
Sep. 30, 2021
Apr. 04, 2022
Dec. 31, 2021
May 04, 2020
Accumulated Other Comprehensive Income (Loss) [Line Items]                                      
Stock issued during period value new issues                           $ 28,939,257          
Number of shares             486,145                        
Accredited investors shares               165,738                      
Equity consideration (fair value)   $ 584,244 $ 584,244                                
Transaction expenses               $ 600,000                      
Share price               $ 30.75                 $ 30.75    
Options to acquire shares               144,191             144,191        
Weighted exercise price               $ 10.71                      
Warrants to purchase shares               4,424                      
Exercise price               $ 7.32                      
Expiration date               Apr. 22, 2031                 Apr. 22, 2031    
Shares Issued, Price Per Share               $ 27.13                      
Cash                                     $ 500,000
Cash consideration             $ 10,000,000.0                        
Granted                             172,986        
Restricted stock award, gross                             $ 4,305,323        
Share-based compensation                     $ 683,202   $ 228,786   1,971,537 $ 852,226      
Accrued liability                                   $ 1,038,183  
Unrecognized share-based compensation expense                     $ 2,999,731       $ 2,999,731        
Unrecognized share-based compensation expense period for recognition                             10 months 24 days        
Precision Healing Inc [Member]                                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                                      
Cash consideration               $ 125,966                      
Payment of contingent consideration               $ 10,000,000.0                      
Rochal Industries LLC [Member]                                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                                      
Stock issued during period new issues, shares                 20,834 20,834                  
Milestone payments                 $ 750,000 $ 750,000                  
Common Stock [Member]                                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                                      
Stock issued during period new issues, shares                           1,265,000          
Stock issued during period value new issues                           $ 1,265          
Accredited investors shares                       165,738 14,369 50,370          
Warrants to purchase shares               12,301                      
Exercise price               $ 12.05                      
Expiration date               Aug. 10, 2030                 Aug. 10, 2030    
Equity Exchange Agreement [Member] | Common Stock [Member]                                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                                      
Stock issued during period new issues, shares           29,536                          
Stock issued during period value new issues                             $ 1,000,000        
Underwriting Agreement [Member]                                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                                      
Number of shares         1,100,000                            
Sale of stock, price per share         $ 25.00                            
Accredited investors shares       165,000 165,000                            
Proceeds from offering         $ 28,900,000                            
Asset Purchase Agreement [Member]                                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                                      
Payments to acquire assets     $ 496,100                                
Issuance of common stock for purchase of assets     14,369                                
Net liabilities   $ 3,900 $ 3,900                                
Purchase Agreement [Member]                                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                                      
Stock issued during period new issues, shares 94,798           94,798                        
Proceeds from offering             $ 1,950,000                        
Payments to acquire assets $ 7,300,000           $ 7,300,000                        
Issuance of common stock for purchase of assets             291,686                        
Cash $ 1,300,000           $ 1,300,000                        
Restated 2014 Omnibus Long Term Incentive Plan [Member]                                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                                      
Number of shares available for issuance                     1,518,805       1,518,805        
Restated 2014 Omnibus Long Term Incentive Plan [Member] | Directors Officers Employees [Member]                                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                                      
Stock issued during period new issues, shares                             481,195